Genetic Technologies Ltd (GENE) — Cash Flow Reinvestment Rate
Genetic Technologies Ltd (GENE) has a Cash Flow Reinvestment Rate of 0.06x as of June 2011, reinvesting $69.84K (capex $69.84K ) from operating cash flow of $1.12 Million. Explore Genetic Technologies Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genetic Technologies Ltd Cash Flow Reinvestment Rate (2007–2011)
Historical reinvestment intensity for Genetic Technologies Ltd across 3 annual periods. Also explore Genetic Technologies Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Genetic Technologies Ltd (2007–2011)
Year-by-year capital reinvestment analysis for Genetic Technologies Ltd. For live market cap and broader valuation context, see Genetic Technologies Ltd (GENE) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.06x | $139.68K | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $118.26K | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $158.87K | $2.20 Million | $158.87K | — |